Demo Reports: Friday, December 30, 2005

Cantor Fitzgerald, Columbia Management, Wachovia Bank and Fulcrum Global

First stop was at the Upper East Side offices of Cantor Fitzgerald's World Headquarters. Cantor is one of the cowardly companies that crawled back to making a market for LSRI (Huntingdon Life Sciences) most likely because of the promise of anonymity by the OTCBB. Needless to say, you cannot hide behind anonymous XXX's when you trade in HLS blood money. We reminded Cantor Fitzgerald how lousy it is having loud, unruly protesters at your front door. Luckily, we didn't throw away our supply of literature naming Cantor Fitzgerald as a primary market maker for LSRI. Maybe they will learn a lesson. You cannot hide from us. If you trade LSRI we always find out and we will bring the fight to close HLS to your front door.

Next stop was the New York office of a relatively new investor, Columbia Management. We couldn't have been more pleased to locate their offices in a posh, upscale hi-rise office building whose anchor tenant is IBM. Columbia Fund which is controlled by Columbia Management owns over 200,000 shares of LSRI stock, worth over $2 million. Columbia Management is owned by Bank of America, which has scores of pretty offices in high visibility, swanky locations all over New York City and across the USA. When will they ever learn? If you invest in puppy killing companies, you will be held responsible for the puppy killing. We are on your case Columbia Management. DIVEST NOW!

On the way to the third of our target companies, we happened to pass a large, very high profile Wachovia Bank branch that was chock full of customers and employees. We felt that we couldn't, in good conscience, pass by without reminding Wachovia that by allowing Robert Ingram of GlaxoSmithKline to continue to serve on their Board of Directors, they continue to have a real liability. Until Robert Ingram is official ousted from the Wachovia board, we will consider Wachovia Bank a target. Activists are planning a full day of Wachovia protests sometime in January. A loud protest followed and promises to come back were made.

We made our way to the offices of Fulcrum Global only to find that they have recently closed their stock trading operation and sold their research facility and staff to Soleil Securities Group. The announcement indicated that although Fulcrum Global sold part of their core function, the rest of their operation would continue. After making a note to keep an eye on this one, we proceeded with a loud and educational demonstration on their front doorstep. Passersby were horrified by the gruesome images of mutilated animals held by protesters and were even more appalled to find out that Fulcrum Global was responsible. If, in fact, we find that Fulcrum has not stopped making a market for LSRI, we will be back in full force to make sure they reconsider.